-
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
Thursday, February 1, 2024 - 9:00am | 809Read More...The global population is experiencing a scary increase in colorectal cancer, especially among young people. Colorectal cancer (CRC) diagnoses have been steadily rising since the 1990s; in 1995 the proportion of these cancer cases in adults younger than 55 was 11%, and in 2019, the number was 20%....
-
Mainz Biomed Partners With Liquid Biosciences In Exclusive Relationship To Harness The Power Of Artificial Intelligence (AI) To Develop Next-Generation Colorectal Screening Test
Monday, November 13, 2023 - 9:24am | 1000Read More...The integration of Artificial Intelligence (AI) in biotechnology is rapidly gaining momentum, revolutionizing the field of life sciences. AI technologies, such as machine learning and deep learning algorithms, have the potential to analyze complex biological data more efficiently and accurately...
-
Mainz Biomed's (NASDAQ: MYNZ) ColoFuture Study Reveals "Groundbreaking Results": ColoAlert® Raises The Bar For Colorectal Cancer Detection
Tuesday, November 7, 2023 - 8:55am | 778Read More...Throughout the world, colorectal cancer has emerged as the third most prevalent form of cancer. Traditionally observed in individuals aged 45 and above, this malignancy is now displaying a troubling trend of affecting younger individuals. Startling data indicates a consistent increase in newly...
-
10 Reasons You May Want To Have Mainz Biomed (NASDAQ: MYNZ) On Your Radar
Tuesday, September 5, 2023 - 8:10am | 1434Read More...The WHO reports that colorectal cancer is the second most fatal cancer around the world. However, it is also the most preventable, with early detection leading to survival rates above 90%. Alarming statistics reveal that new cases of colorectal cancer in individuals under the age of 50 have been...
-
Second Most Fatal Cancer In U.S. May Face A Big Fight From Mainz Biomed's Non-Invasive Test; (NASDAQ: MYNZ) Is Making Early Detection Possible
Tuesday, August 29, 2023 - 8:43am | 902Read More...Colorectal cancer is the third most common cancer worldwide, and the second most fatal. Although the majority of colorectal cancer cases have historically occurred in individuals aged 50 and older, it is increasingly affecting younger people. Alarming statistics reveal that new cases of...






